This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Cellestia Biotech Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Charlotte Urech in Cancer Treatment
Introduction
Charlotte Urech is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the Notch signaling pathway, which plays a crucial role in various cellular processes.
Latest Patents
Charlotte Urech holds 1 patent for her invention titled "Inhibitors of Notch signaling pathway and use thereof in treatment of cancers." This patent relates to new inhibitors of the Notch signaling pathway and their application in the treatment and prevention of cancers. Her research aims to provide new therapeutic options for patients suffering from this devastating disease.
Career Highlights
Charlotte Urech has established herself as a key figure in the biotechnology sector. She is currently associated with Cellestia Biotech AG, where she continues to advance her research in cancer therapies. Her dedication to innovation has positioned her as a leader in her field.
Collaborations
Charlotte collaborates with esteemed colleagues, including Guido Bold and Vincent Zoete. These partnerships enhance her research efforts and contribute to the development of effective cancer treatments.
Conclusion
Charlotte Urech's work exemplifies the impact of innovative research in the fight against cancer. Her contributions to the Notch signaling pathway represent a significant advancement in therapeutic options for patients.